Fear-potentiated behaviour is modulated by central amygdala angiotensin II A T1 receptors stimulation

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Marinzalda, Maria De Los Angeles ^a   Pérez, Pablo A ^a   Gargiulo, Pascual A ^b   Casarsa, Brenda S ^a   Bregonzio, Claudia ^c   Baiardi, Gustavo ^a  

^a UNIVERSIDAD CATÓLICA DE CÓRDOBA   (Argentina)

^b UNIVERSIDAD NACIONAL DE CUYO   (Argentina)

^c UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; LOSARTAN; SODIUM CHLORIDE; ANGIOTENSIN II;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; DRUG EFFECT; FEAR; FEAR POTENTIATED BEHAVIOR; FOOTSHOCK; GROOMING; HISTOLOGY; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; RAT; ANIMAL; ANIMAL BEHAVIOR; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; TIME; WISTAR RAT;

ANGIOTENSIN II; ANIMALS; BEHAVIOR, ANIMAL; CENTRAL AMYGDALOID NUCLEUS; FEAR; GROOMING; MALE; MAZE LEARNING; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; TIME FACTORS;

EID: 84903649919     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/183248     Document Type: Article

References (40)

1. Lavoie J. L., Sigmund C. D., Minireview: overview of the renin-angiotensin system-an endocrine and paracrine system. Endocrinology 2003 144 6 2179 2183 2-s2.0-0037901037 10.1210/en.2003-0150 (Pubitemid 36629863)
2. Danser A. H. J., Local renin-angiotensin systems: the unanswered questions. International Journal of Biochemistry and Cell Biology 2003 35 6 759 768 2-s2.0-0037409309 10.1016/S1357-2725(02)00178-4 (Pubitemid 36379316)
3. Saavedra J. M., Brain and pituitary angiotensin. Endocrine Reviews 1992 13 2 329 380 2-s2.0-0026773791 10.1210/er.13.2.329
4. Saavedra J. M., Armando I., Bregonzio C., Juorio A., Macova M., Pavel J., Sanchez-Lemus E., A centrally acting, anxiolytic angiotensin II AT1 receptor antagonist prevents the isolation stress-induced decrease in cortical CRF 1 receptor and benzodiazepine binding. Neuropsychopharmacology 2006 31 6 1123 1134 2-s2.0-33745664016 10.1038/sj.npp.1300921 (Pubitemid 43971830)
5. Shekhar A., Sajdyk T. J., Gehlert D. R., Rainnie D. G., The amygdala, panic disorder, and cardiovascular responses. Annals of the New York Academy of Sciences 2003 985 308 325 2-s2.0-0037279890 (Pubitemid 36521123)
6. Bohus B., Koolhaas J. M., Korte S. M., Roozendaal B., Wiersma A., Forebrain pathways and their behavioural interactions with neuroendocrine and cardiovascular function in the rat. Clinical and Experimental Pharmacology and Physiology 1996 23 2 177 182 2-s2.0-0030075105 (Pubitemid 126735524)
7. Saha S., Role of the central nucleus of the amygdala in the control of blood pressure: descending pathways to medullary cardiovascular nuclei. Clinical and Experimental Pharmacology and Physiology 2005 32 5-6 450 456 2-s2.0-20344398002 10.1111/j.1440-1681.2005.04210.x (Pubitemid 40780274)
8. Watanabe M. A., Kucenas S., Bowman T. A., Ruhlman M., Knuepfer M. M., Angiotensin II and CRF receptors in the central nucleus of the amygdala mediate hemodynamic response variability to cocaine in conscious rats. Brain Research 2010 1309 53 65 2-s2.0-72049095044 10.1016/j.brainres.2009.10.059
9. Walker D. L., Davis M., Involvement of NMDA receptors within the amygdala in short- versus long-term memory for fear conditioning as assessed with fear-potentiated startle. Behavioral Neuroscience 2000 114 6 1019 1033 2-s2.0-0034538675 10.1037//0735-7044.114.6.1019 (Pubitemid 32001882)
10. Pitkänen A., Pikkarainen M., Nurminen N., Ylinen A., Reciprocal connections between the amygdala and the hippocampal formation, perirhinal cortex, and postrhinal cortex in rat. Annals of the New York Academy of Sciences 2000 911 369 391 2-s2.0-0033913866 (Pubitemid 30462094)
11. Gray T. S., Carney M. E., Magnuson D. J., Direct projections from the central amygdaloid nucleus to the hypothalamic paraventricular nucleus: possible role in stress-induced adrenocorticotropin release. Neuroendocrinology 1989 50 4 433 446 2-s2.0-0024452054 (Pubitemid 19245964)
12. Marowsky A., Fritschy J. M., Vogt K. E., Functional mapping of GABAA receptor subtypes in the amygdala. European Journal of Neuroscience 2004 20 5 1281 1289 2-s2.0-4544221777 10.1111/j.1460-9568.2004.03574.x (Pubitemid 39233581)
13. von Bohlen und Halbach O., Albrecht D., Visualization of specific angiotensin II binding sites in the rat limbic system. Neuropeptides 1998 32 3 241 245 2-s2.0-13144294010 10.1016/S0143-4179(98)90043-9 (Pubitemid 28267144)
14. Korte S. M., de Boer S. F., A robust animal model of state anxiety: fear-potentiated behaviour in the elevated plus-maze. European Journal of Pharmacology 2003 463 1-3 163 175 2-s2.0-0037470187 10.1016/S0014-2999(03)01279- 2 (Pubitemid 36205078)
15. Paxinos G., The Rat Brain in Stereotaxic Coordinates 1997 New York, NY, USA Academic Press
16. Llano-López L. H., Caif F., García S., Fraile M., Landa A. I., Baiardi G., Lafuente J. V., Braszko J. J., Bregonzio C., Gargiulo P. A., Anxiolytic-like effect of losartan injected into amygdala of the acutely stressed rats. Pharmacological Reports 2012 64 1 54 63 2-s2.0-84862203302
17. Nin M. S., Couto-Pereira N. S., Souza M. F., Azeredo L. A., Ferri M. K., Dalprá W. L., Gomez R., Barros H. M. T., Anxiolytic effect of clonazepam in female rats: grooming microstructure and elevated plus maze tests. European Journal of Pharmacology 2012 684 1-3 95 101 2-s2.0-84860837742 10.1016/j.ejphar.2012.03.038
18. Gispen W. H., Isaacson R. L., ACTH-induced excessive grooming in the rat. Pharmacology and Therapeutics 1981 12 1 209 246 2-s2.0-0019379136 (Pubitemid 11183307)
19. Gonzalez L. E., File S. E., A five minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus. Journal of Neuroscience 1997 17 4 1505 1511 2-s2.0-0031015742 (Pubitemid 27073749)
20. Lister R. G., Ethologically-based animal models of anxiety disorders. Pharmacology and Therapeutics 1990 46 3 321 340 2-s2.0-0025321231 (Pubitemid 20108519)
21. Wall P. M., Messier C., Methodological and conceptual issues in the use of the elevated plus-maze as a psychological measurement instrument of animal anxiety-like behavior. Neuroscience and Biobehavioral Reviews 2001 25 3 275 286 2-s2.0-0034980121 10.1016/S0149-7634(01)00013-6 (Pubitemid 32506878)
22. Fernandes C., File S. E., The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacology Biochemistry and Behavior 1996 54 1 31 40 2-s2.0-0029968928 10.1016/0091-3057(95)02171-X (Pubitemid 26143090)
23. LeDoux J. E., Emotion: clues from the brain. Annual Review of Psychology 1995 46 209 235 2-s2.0-0029107645
24. Marvar P. J., Goodman J., Fuchs S., Choi D. C., Banerjee S., Ressler K. J., Angiotensin type 1 receptor inhibition enhances the extinction of fear memory. Biological Psychiatry 2014 75 11 864 872 10.1016/j.biopsych.2013.08.024
25. Kaiser F. C., Palmer G. C., Wallace A. V., Carr R. D., Fraser-Rae L., Hallam C., Antianxiety properties of the angiotensin II antagonist, DUP 753, in the rat using the elevated plus-maze. NeuroReport 1992 3 10 922 924 2-s2.0-0026767755
26. Kułakowska A., Karwowska W., Wiśniewski K., Braszko J. J., Losartan influences behavioural effects of angiotensin II in rats. Pharmacological Research 1996 34 3-4 109 115 2-s2.0-0030240328 10.1006/phrs.1996.0073 (Pubitemid 27075999)
27. Wilson W., Voigt P., Bader M., Marsden C. A., Fink H., Behaviour of the transgenic (mREN2)27 rat. Brain Research 1996 729 1 1 9 2-s2.0-0030570777 10.1016/S0006-8993(96)00114-X (Pubitemid 26276174)
28. Albrecht D., Nitschke T., von Bohlen Und Halbach O., Various effects of angiotensin II on amygdaloid neuronal activity in normotensive control and hypertensive transgenic [TGR(mREN-2)27] rats. The FASEB Journal 2000 14 7 925 931 2-s2.0-0034109876 (Pubitemid 30241669)
29. Breigeiron M. K., Morris M., Lucion A. B., Sanvitto G. L., Effects of angiotensin II microinjected into medial amygdala on male sexual behavior in rats. Hormones and Behavior 2002 41 3 267 274 2-s2.0-0036246555 10.1006/hbeh.2002.1771 (Pubitemid 34499454)
30. Cecconello A. L., Raineki C., Sebben V., Lucion A. B., Sanvitto G. L., Effect of acute stress on sexual behavior in female rats: participation of the central angiotensinergic system. Behavioural Brain Research 2010 207 2 429 433 2-s2.0-74449092608 10.1016/j.bbr.2009.10.026
31. Saavedra J. M., Ando H., Armando I., Baiardi G., Bregonzio C., Juorio A., Macova M., Anti-stress and anti-anxiety effects of centrally acting angiotensin II AT1 receptor antagonists. Regulatory Peptides 2005 128 3 227 238 2-s2.0-17444367355 10.1016/j.regpep.2004.12.015 (Pubitemid 40544838)
32. Saavedra J. M., Benicky J., Brain and peripheral angiotensin II play a major role in stress. Stress 2007 10 2 185 193 2-s2.0-34249095106 10.1080/10253890701350735 (Pubitemid 46789475)
33. Bregonzio C., Armando I., Ando H., Jezova M., Baiardi G., Saavedra J. M., Anti-inflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury. The American Journal of Physiology- Gastrointestinal and Liver Physiology 2003 285 2 G414 G423 2-s2.0-0038779799 (Pubitemid 36875214)
34. Srinivasan J., Suresh B., Ramanathan M., Differential anxiolytic effect of enalapril and losartan in normotensive and renal hypertensive rats. Physiology and Behavior 2003 78 4-5 585 591 2-s2.0-0038356478 10.1016/S0031-9384(03)00036-2 (Pubitemid 36628085)
35. Braszko J., Valsartan abolishes most of the memory-improving effects of intracerebroventricular angiotensin II in rats. Clinical and Experimental Hypertension 2005 27 8 635 649 2-s2.0-28444444152 10.1080/10641960500298723 (Pubitemid 41722070)
36. Raasch W., Wittmershaus C., Dendorfer A., Voges I., Pahlke F., Dodt C., Dominiak P., Jöhren O., Angiotensin II inhibition reduces stress sensitivity of hypothalamo-pituitary-adrenal axis in spontaneously hypertensive rats. Endocrinology 2006 147 7 3539 3546 2-s2.0-33745136818 10.1210/en.2006-0198 (Pubitemid 43901145)
37. Brown D. C., Steward L. J., Ge J., Barnes N. M., Ability of angiotensin II to modulate striatal dopamine release via the AT1 receptor in vitro and in vivo. The British Journal of Pharmacology 1996 118 2 414 420 2-s2.0-0029983547 (Pubitemid 26149291)
38. Raghavendra V., Chopra K., Kulkarni S. K., Modulation of motor functions involving the dopaminergic system by AT1 receptor antagonist, losartan. Neuropeptides 1998 32 3 275 280 2-s2.0-0031833474 10.1016/S0143-4179(98)90048-8 (Pubitemid 28267149)
39. Georgiev V., Gyorgy L., Getova D., Markovska V., Some central effects of angiotensin II. Interactions with dopaminergic transmission. Acta Physiologica et Pharmacologica Bulgarica 1985 11 4 19 26 2-s2.0-0022399115 (Pubitemid 16165281)
40. Jenkins T. A., Allen A. M., Chai S. Y., MacGregor D. P., Paxinos G., Mendelsohn F. A. O., Interactions of angiotensin II with central dopamine. Advances in Experimental Medicine and Biology 1996 396 93 103 2-s2.0-0030012832 (Pubitemid 26164391)